AusculSciences Canada Inc.
AusculSciences is a medical device, services, and software solutions company dedicated to developing bio-acoustic technologies for detecting cardiovascular and pulmonary conditions. They focus on non-invasive, non-stressful, and cost-effective diagnostic tools that support clinical decision-making, improve patient comfort, and reduce healthcare costs. Their innovative solutions include the Auscul-X Touchless Stethoscope System and the CAD-det System, which aim to enhance safety and accuracy in medical diagnostics.
Industries
Nr. of Employees
small (1-50)
AusculSciences Canada Inc.
8230 Leesburg Pike, Vienna, VA 22182
Patents
Products
Acoustic-based non-invasive CAD detection system
A rapid, non-invasive diagnostic system that acquires cardiac acoustic data, processes it into clinician-facing representations, and applies machine‑learning analysis to assist in detection or rule-out of obstructive coronary artery disease.
Remote disposable touchless stethoscope system
A professional-grade system comprising single-use adhesive acoustic sensors, a patient-side hub, an in-room control unit and a wireless app for clinicians to listen to and visualize heart and lung sounds from outside patient rooms.
Acoustic-based non-invasive CAD detection system
A rapid, non-invasive diagnostic system that acquires cardiac acoustic data, processes it into clinician-facing representations, and applies machine‑learning analysis to assist in detection or rule-out of obstructive coronary artery disease.
Remote disposable touchless stethoscope system
A professional-grade system comprising single-use adhesive acoustic sensors, a patient-side hub, an in-room control unit and a wireless app for clinicians to listen to and visualize heart and lung sounds from outside patient rooms.
Services
Design and conduct of investigational device studies enrolling patients scheduled for CCTA or invasive coronary angiography to collect paired device and reference-imaging data for algorithm training and validation.
Deployment of web-based management software for clinician review, device status monitoring, annotation, and EHR integration; supports remote and local operations.
Supply and configuration of remote, disposable auscultation sensor systems for evaluation in clinical settings and government test programs.
Delivery of recorded auscultation sample sets and comparative audio benchmarks for technical evaluation and sound-quality assessment.
Design and conduct of investigational device studies enrolling patients scheduled for CCTA or invasive coronary angiography to collect paired device and reference-imaging data for algorithm training and validation.
Deployment of web-based management software for clinician review, device status monitoring, annotation, and EHR integration; supports remote and local operations.
Supply and configuration of remote, disposable auscultation sensor systems for evaluation in clinical settings and government test programs.
Delivery of recorded auscultation sample sets and comparative audio benchmarks for technical evaluation and sound-quality assessment.
Expertise Areas
- Acoustic-based diagnostic devices
- Clinical trial management and multicenter patient recruitment
- Machine learning for biosignal / acoustic biomarker detection
- Remote patient monitoring and tele-auscultation
Key Technologies
- Multichannel skin-mounted acoustic sensors
- Wireless (Wi‑Fi) streaming and mobile/desktop auscultation apps
- Machine learning / AI for acoustic biomarker detection
- Web-based clinical device management (server/cloud)
News & Updates
AusculSciences exhibited its CAD-det System at the 2018 CCC, showcasing its potential to disrupt standard care for CAD detection.
AusculSciences presented its CAD-det System at the summit, highlighting its non-invasive approach to improving CAD detection in women.
The company announced that over 500 patients have undergone successful CAD-det System tests in clinical studies.
Over 1,000 individuals have been tested with the CAD-det System, with recruitment expanding across multiple Canadian centers.
The company announced successful completion of the ISO 13485 MDSAP certification audit, enabling market access in Canada.
The company showcased its CAD-det System at major Canadian healthcare events, emphasizing its potential to change clinical cardiology practice.
AusculSciences exhibited its CAD-det System at the 2018 CCC, showcasing its potential to disrupt standard care for CAD detection.
AusculSciences presented its CAD-det System at the summit, highlighting its non-invasive approach to improving CAD detection in women.
The company announced that over 500 patients have undergone successful CAD-det System tests in clinical studies.
Over 1,000 individuals have been tested with the CAD-det System, with recruitment expanding across multiple Canadian centers.
The company announced successful completion of the ISO 13485 MDSAP certification audit, enabling market access in Canada.
The company showcased its CAD-det System at major Canadian healthcare events, emphasizing its potential to change clinical cardiology practice.